COMMUNIQUÉS West-GlobeNewswire

-
Rexahn Effects 1-for-12 Reverse Stock Split
12/04/2019 -
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial
12/04/2019 -
CymaBay Therapeutics Presents Positive Phase 2 Data for Seladelpar in Patients with Primary Biliary Cholangitis at the International Liver Congress™ 2019
12/04/2019 -
FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo®)
12/04/2019 -
Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference
12/04/2019 -
Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress™ 2019 (EASL)
12/04/2019 -
Better Choice Company Signs Memorandum of Understanding with Nutrisur S.A. for Development Rights of CBD Infused Pet Supplements
12/04/2019 -
TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
12/04/2019 -
Information on changes in the Management Boards of the subsidiaries of JSC Olainfarm and in authorization rights
12/04/2019 -
Spring Bank Announces Positive Results from the Recently Completed Phase 2 Chronic Hepatitis B ACHIEVE Trial and Additional Inarigivir Studies
12/04/2019 -
Aleafia Health Applauds Commitment to Private Retail Expansion in Ontario Budget
12/04/2019 -
AroCell´s 2018 Annual Report published
12/04/2019 -
GN Audio upgrades financial guidance for 2019
12/04/2019 -
Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
12/04/2019 -
DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
12/04/2019 -
Basilea reports isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) presentations at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
12/04/2019 -
PhaseBio Announces Pricing of Public Offering of Common Stock
12/04/2019 -
Cooper Fitness Center Introduces Move.Laugh.Connect. Program
11/04/2019 -
Cerner and naviHealth Expand Relationship, Plan to Launch Offering for Bundled Payments for Care Improvement Advanced (BPCI Advanced)
11/04/2019
Pages